Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.410
+0.047 (3.45%)
At close: Apr 13, 2026, 4:00 PM EDT
1.402
-0.008 (-0.60%)
After-hours: Apr 13, 2026, 7:59 PM EDT
Quince Therapeutics Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Quince Therapeutics in the last 12 months.
Price Target: n/a
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Quince Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 30, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 30, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $50 | Strong Buy | Maintains | $50 | +3,446.10% | Jan 29, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $40 → $50 | Strong Buy | Maintains | $40 → $50 | +3,446.10% | Dec 15, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $40 | Strong Buy | Maintains | $40 | +2,736.88% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
20.62M
EPS This Year
-1.04
from -16.80
EPS Next Year
-1.07
from -1.04
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | 53.7M | |||
| Avg | n/a | 20.6M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.75 | -0.48 | |
| Avg | -1.04 | -1.07 | |
| Low | -1.50 | -1.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.